Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 132

1.

Comparison of different chemically modified inhibitors of miR-199b in vivo.

Duygu B, Juni R, Ottaviani L, Bitsch N, Wit JBM, de Windt LJ, da Costa Martins PA.

Biochem Pharmacol. 2018 Nov 16;159:106-115. doi: 10.1016/j.bcp.2018.11.013. [Epub ahead of print]

2.

A novel murine model for arrhythmogenic cardiomyopathy points to a pathogenic role of Wnt signaling and miRNA dysregulation.

Calore M, Lorenzon A, Vitiello L, Poloni G, Khan MAF, Beffagna G, Dazzo E, Sacchetto C, Polishchuk R, Sabatelli P, Doliana R, Carnevale D, Lembo G, Bonaldo P, De Windt L, Braghetta P, Rampazzo A.

Cardiovasc Res. 2018 Oct 10. doi: 10.1093/cvr/cvy253. [Epub ahead of print]

PMID:
30304392
3.

Considering parental hearing status as a social determinant of deaf population health: Insights from experiences of the "dinner table syndrome".

Hall WC, Smith SR, Sutter EJ, DeWindt LA, Dye TDV.

PLoS One. 2018 Sep 5;13(9):e0202169. doi: 10.1371/journal.pone.0202169. eCollection 2018.

4.

Non-coding RNA function in stem cells and Regenerative Medicine.

De Windt LJ, Giacca M.

Noncoding RNA Res. 2018 Apr 20;3(2):39-41. doi: 10.1016/j.ncrna.2018.04.004. eCollection 2018 Jun. No abstract available.

5.

RNA therapeutics for heart disease.

De Majo F, De Windt LJ.

Biochem Pharmacol. 2018 Sep;155:468-478. doi: 10.1016/j.bcp.2018.07.037. Epub 2018 Jul 29. Review.

PMID:
30059676
6.

If you like it, put a ring on it!

El Azzouzi H, De Windt LJ.

Cardiovasc Res. 2018 Oct 1;114(12):1575-1577. doi: 10.1093/cvr/cvy190. No abstract available.

PMID:
30052806
7.

The MEF2 transcriptional target DMPK induces loss of sarcomere structure and cardiomyopathy.

Damanafshan A, Elzenaar I, Samson-Couterie B, van der Made I, Bourajjaj M, van den Hoogenhof MM, van Veen HA, Picavet DI, Beqqali A, Ehler E, De Windt LJ, Pinto YM, van Oort RJ.

Cardiovasc Res. 2018 Sep 1;114(11):1474-1486. doi: 10.1093/cvr/cvy091.

PMID:
29648621
8.

The innate immune system in chronic cardiomyopathy: a European Society of Cardiology (ESC) scientific statement from the Working Group on Myocardial Function of the ESC.

Frantz S, Falcao-Pires I, Balligand JL, Bauersachs J, Brutsaert D, Ciccarelli M, Dawson D, de Windt LJ, Giacca M, Hamdani N, Hilfiker-Kleiner D, Hirsch E, Leite-Moreira A, Mayr M, Thum T, Tocchetti CG, van der Velden J, Varricchi G, Heymans S.

Eur J Heart Fail. 2018 Mar;20(3):445-459. doi: 10.1002/ejhf.1138. Epub 2018 Jan 15. Review.

9.

MicroRNA-221/222 Family Counteracts Myocardial Fibrosis in Pressure Overload-Induced Heart Failure.

Verjans R, Peters T, Beaumont FJ, van Leeuwen R, van Herwaarden T, Verhesen W, Munts C, Bijnen M, Henkens M, Diez J, de Windt LJ, van Nieuwenhoven FA, van Bilsen M, Goumans MJ, Heymans S, González A, Schroen B.

Hypertension. 2018 Feb;71(2):280-288. doi: 10.1161/HYPERTENSIONAHA.117.10094. Epub 2017 Dec 18.

PMID:
29255073
10.

An integrative translational approach to study heart failure with preserved ejection fraction: a position paper from the Working Group on Myocardial Function of the European Society of Cardiology.

Lourenço AP, Leite-Moreira AF, Balligand JL, Bauersachs J, Dawson D, de Boer RA, de Windt LJ, Falcão-Pires I, Fontes-Carvalho R, Franz S, Giacca M, Hilfiker-Kleiner D, Hirsch E, Maack C, Mayr M, Pieske B, Thum T, Tocchetti CG, Brutsaert DL, Heymans S.

Eur J Heart Fail. 2018 Feb;20(2):216-227. doi: 10.1002/ejhf.1059. Epub 2017 Nov 16. Review.

PMID:
29148148
11.

An unbiased silencing screen in muscle cells identifies miR-320a, miR-150, miR-196b, and miR-34c as regulators of skeletal muscle mitochondrial metabolism.

Dahlmans D, Houzelle A, Andreux P, Jörgensen JA, Wang X, de Windt LJ, Schrauwen P, Auwerx J, Hoeks J.

Mol Metab. 2017 Nov;6(11):1429-1442. doi: 10.1016/j.molmet.2017.08.007. Epub 2017 Aug 31.

12.

Wnt/β-catenin pathway in arrhythmogenic cardiomyopathy.

Lorenzon A, Calore M, Poloni G, De Windt LJ, Braghetta P, Rampazzo A.

Oncotarget. 2017 Apr 27;8(36):60640-60655. doi: 10.18632/oncotarget.17457. eCollection 2017 Sep 1. Review.

13.

Translational Perspective on Epigenetics in Cardiovascular Disease.

van der Harst P, de Windt LJ, Chambers JC.

J Am Coll Cardiol. 2017 Aug 1;70(5):590-606. doi: 10.1016/j.jacc.2017.05.067. Review.

14.

Why publish in the American Journal of Physiology-Heart and Circulatory Physiology?

Zucker IH, Lindsey ML, Delmar M, De Windt LJ, Des Rosiers C, Diz DI, Hester RL, Jones SP, Kanagy NL, Kitakaze M, Liao R, Lopaschuk GD, Patel KP, Recchia FA, Sadoshima J, Shah AM, Ungvari Z, Benjamin IJ, Blaustein MP, Charkoudian N, Efimov IR, Gutterman D, Kass DA, Liao Y, O'Leary DS, Ripplinger CM, Wolin MS.

Am J Physiol Heart Circ Physiol. 2017 Aug 1;313(2):H221-H223. doi: 10.1152/ajpheart.00329.2017. Epub 2017 Jun 16. No abstract available.

15.

Cardiac remodeling and pre-eclampsia: an overview of microRNA expression patterns.

Mohseni Z, Spaanderman MEA, Oben J, Calore M, Derksen E, Al-Nasiry S, de Windt LJ, Ghossein-Doha C.

Ultrasound Obstet Gynecol. 2018 Sep;52(3):310-317. doi: 10.1002/uog.17516. Review.

PMID:
28466998
16.

Epigenomic and transcriptomic approaches in the post-genomic era: path to novel targets for diagnosis and therapy of the ischaemic heart? Position Paper of the European Society of Cardiology Working Group on Cellular Biology of the Heart.

Perrino C, Barabási AL, Condorelli G, Davidson SM, De Windt L, Dimmeler S, Engel FB, Hausenloy DJ, Hill JA, Van Laake LW, Lecour S, Leor J, Madonna R, Mayr M, Prunier F, Sluijter JPG, Schulz R, Thum T, Ytrehus K, Ferdinandy P.

Cardiovasc Res. 2017 Jun 1;113(7):725-736. doi: 10.1093/cvr/cvx070. Review.

17.

Collaboration With Deaf Communities to Conduct Accessible Health Surveillance.

Barnett SL, Matthews KA, Sutter EJ, DeWindt LA, Pransky JA, O'Hearn AM, David TM, Pollard RQ, Samar VJ, Pearson TA.

Am J Prev Med. 2017 Mar;52(3S3):S250-S254. doi: 10.1016/j.amepre.2016.10.011.

18.

miR-199b-5p is a regulator of left ventricular remodeling following myocardial infarction.

Duygu B, Poels EM, Juni R, Bitsch N, Ottaviani L, Olieslagers S, de Windt LJ, da Costa Martins PA.

Noncoding RNA Res. 2017 Jan 13;2(1):18-26. doi: 10.1016/j.ncrna.2016.12.002. eCollection 2017 Mar.

19.

Pre-eclampsia: an important risk factor for asymptomatic heart failure.

Ghossein-Doha C, van Neer J, Wissink B, Breetveld NM, de Windt LJ, van Dijk AP, van der Vlugt MJ, Janssen MC, Heidema WM, Scholten RR, Spaanderman ME.

Ultrasound Obstet Gynecol. 2017 Jan;49(1):143-149. doi: 10.1002/uog.17343.

20.

Preclinical Development of a MicroRNA-Based Therapy for Elderly Patients With Myocardial Infarction.

Gupta SK, Foinquinos A, Thum S, Remke J, Zimmer K, Bauters C, de Groote P, Boon RA, de Windt LJ, Preissl S, Hein L, Batkai S, Pinet F, Thum T.

J Am Coll Cardiol. 2016 Oct 4;68(14):1557-71. doi: 10.1016/j.jacc.2016.07.739.

Supplemental Content

Loading ...
Support Center